Endoscopic Devices - Germany | Statista Market Forecast

Revenue in the Endoscopic Devices market market in Germany is anticipated to reach US$2.29bn in 2024.
This revenue is projected to exhibit an annual growth rate (CAGR 2024-2029) of 7.28%, culminating in a market volume of US$3.26bn by 2029.
In a global context, the majority of revenue is expected to be generated the United States, with figures amounting to US$10.39bn in 2024.
Germany's robust healthcare system is increasingly adopting advanced endoscopic devices, driven by a growing emphasis on minimally invasive procedures and patient outcomes.

Definition:
The Endoscopic Devices market, a medical technology market, includes the sale of endoscopic devices. Endoscopy involves the use of an endoscope to examine the inside of a hollow organ or body cavity. The market includes various types of endoscopes, such as gastroscopes, laparoscopes, bronchoscopes, and colonoscopes.

Additional information:
Market values represent revenues paid to primary vendors at manufacturer price level either directly or through distribution channels (excluding VAT). Reported market revenues include spending by consumers (B2C), enterprises (B2B), and governments (B2G). Revenues are allocated to the country where the money is spent.

Key players in the market include Olympus Corporation, Boston Scientific Corporation, and Stryker Corporation. Further information on the key players can be found in the Market Shares boxes.

Endoscopic devices
Implants such as stents

pharmaceuticals for endoscopic procedure

The Endoscopic Devices Market in Germany is experiencing moderate growth, influenced by factors such as advancements in minimally invasive techniques, increasing demand for diagnostic procedures, and heightened awareness of early disease detection among healthcare providers and patients.

Customer preferences: Consumers in Germany are increasingly prioritizing proactive health management and preventive care, driving a growing interest in endoscopic procedures for early disease detection. This trend reflects a cultural shift towards wellness and longevity, with younger demographics showing heightened awareness of health issues. Additionally, the aging population is influencing preferences for less invasive treatment options, as patients seek quicker recovery times and reduced hospital stays. As a result, there is a rising demand for innovative endoscopic devices that enhance diagnostic accuracy and patient comfort.

Trends in the market: In Germany, the Endoscopic Devices Market is experiencing a surge in demand for minimally invasive procedures, driven by increased patient awareness and a cultural shift towards preventive healthcare. This trend is reflected in the growing adoption of advanced endoscopic technologies that offer improved diagnostic capabilities and enhanced patient experiences. The aging population is further fueling this growth, as older patients prefer quicker recovery options. Consequently, industry stakeholders must innovate continuously and adapt to these evolving preferences to remain competitive and meet the rising expectations for quality and efficiency in healthcare delivery.

Local special circumstances: In Germany, the Endoscopic Devices Market is shaped by a robust healthcare infrastructure and stringent regulatory standards that ensure high-quality medical devices. The country's emphasis on patient safety and efficacy promotes the adoption of innovative endoscopic technologies. Additionally, a well-informed patient population drives demand for minimally invasive options, aligning with cultural preferences for quicker recovery and less invasive procedures. Regional variations in healthcare access also influence market dynamics, as urban areas often exhibit higher adoption rates compared to rural regions, necessitating targeted marketing strategies.

Underlying macroeconomic factors: The Endoscopic Devices Market in Germany is significantly influenced by macroeconomic factors including national economic stability, investment in healthcare infrastructure, and global economic trends. A strong economy fosters increased healthcare spending, enabling hospitals to invest in advanced endoscopic technologies. Favorable fiscal policies, such as government incentives for medical innovation, further stimulate market growth. Additionally, the aging population and rising prevalence of chronic diseases heighten the demand for minimally invasive procedures. Global supply chain dynamics also play a crucial role, impacting the availability and cost of endoscopic devices, ultimately shaping market performance.

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.

Modeling approach / Market size:

Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

Medical technology plays a role in the lives of everyone. It includes most of all, medical devices which simplify the prevention, diagnosis, and treatment of diseases and illnesses. The most well-known medical technology products are, among others, pacemakers, imaging instruments, dialysis machines, and implants. The global medical technology industry was worth over 567 billion U.S. dollars annually. Established centers of this industry include North America and Western Europe. The United States is home to the world’s largest medical technology companies. As of 2022, Abbott Laboratories had the largest global revenue at over 31.2 billion U.S. dollars. The main focus of devices manufactured by the Chicago-based company are diagnostics, cardiovascular, and diabetes care. Two other medtech companies that round off the top three largest companies –Medtronic and Johnson & Johnson – are both based in the United States. Although, industry trends show that Asia, and in particular China, is about to play a more prominent role in the years to come.